Protein kinase C β enhances growth and expression of cyclin D1 in human breast cancer cells

Cancer Research

Volumn 66, Issue 23, 2006, Pages 11399-11408

  Li, Haiyang ^a   Weinstein, I Bernard ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; LY 379196; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA1; PROTEIN KINASE C BETA2; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE; CELL GROWTH; DRUG EFFECT; HUMAN; HUMAN CELL; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CELL DIVISION; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOBLOTTING; ISOENZYMES; LUCIFERASES; MESYLATES; MUTATION; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-FOS; PYRROLES; RECOMBINANT FUSION PROTEINS; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

EID: 33845732645     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-2386     Document Type: Article

References (48)

1. Saito N, Kikkawa U, Nishizuka Y. The family of protein kinase C and membrane lipid mediators. J Diabetes Complications 2002;16:4-8.
2. Dekker LV, Parker PJ. Protein kinase C-a question of specificity. Trends Biochem Sci 1994;19:73-7.
3. Newton AC. Protein kinase C: structure, function, and regulation. J Biol Chem 1995;270:28495-8.
4. Mansour SJ, Matten WT, Hermann AS, et al. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 1994;265:966-70.
5. Amundadottir LT, Leder P. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes. Oncogene 1998;16:737-46.
6. O'Brian C, Vogel VG, Singletary SE, Ward NE. Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. Cancer Res 1989;49:3215-7.
7. Gordge PC, Hulme MJ, Clegg RA, Miller WR. Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue. Eur J Cancer 1996;32A:2120-6.
8. 2+-dependent protein kinase of human mammary carcinoma cells: inverse relationship to estrogen receptors. Int J Cancer 1987;40:344-8.
9. Fabbro D, Kung W, Costa SD, Borner C, Regenass U, Eppenberger U. Involvement of protein kinase C in the growth regulation of human breast cancer cells. Cancer Treat Res 1992;61:229-48.
10. Bignon E, Ogita K, Kishimoto A, Nishizuka Y. Protein kinase C subspecies in estrogen receptor-positive and - negative human breast cancer cell lines. Biochem Biophys Res Commun 1990;171:1071-8.
11. Davidson NE, Kennedy MJ. Protein kinase C and breast cancer. Cancer Treat Res 1996;83:91-105.
12. Gokmen-Polar Y, Murray NR, Velasco MA, Gatalica Z, Fields AP. Elevated protein kinase C βII is an early promotive event in colon carcinogenesis. Cancer Res 2001;61:1375-81.
13. Murray NR, Davidson LA, Chapkin RS, Clay Gustafson W, Schattenberg DG, Fields AP. Overexpression of protein kinase C βII induces colonic hyperproliferation and increased sensitivity to colon carcinogenesis. J Cell Biol 1999;145:699-711.
14. Yu W, Murray NR, Weems C, et al. Role of cyclooxygenase 2 in protein kinase C βII-mediated colon carcinogenesis. J Biol Chem 2003;278:11167-74.
15. Maruvada P, Levine AE. Increased transforming growth factor-α levels in human colon carcinoma cell unes over-expressing protein kinase C. Int J Cancer 1999;80:72-7.
16. Soh JW, Weinstein IB. Roles of specific isoforms of protein kinase C in the transcriptional control of cyclin D1 and related genes. J Biol Chem 2003;278:34709-16.
17. Keyomarsi K, Pardee AB. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci U S A 1993;90:1112-6.
18. Gillett C, Fantl V, Smith R, et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994;54:1812-7.
19. Arnold A. The cyclin D1/PRAD1 oncogene in human neoplasia. J Investig Med 1995;43:543-9.
20. Hunter T, Pines J. Cyclins and cancer. II: cyclin D and CDK inhibitors come of age. Cell 1994;79:573-82.
21. 1-phase progression. Genes Dev 1999;13:1501-12.
22. Albanese C, Johnson J, Watanabe G, et al. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem 1995;270:23589-97.
23. Shtutman M, Zhurinsky J, Simcha I, et al. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A 1999;96:5522-7.
24. Tetsu O, McCormick F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398:422-6.
25. Jirousek MR, Gillig JR, Gonzalez CM, et al. (S)-13-((Dimethylamino) methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo [3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C β. J Med Chem 1996;39:2664-71.
26. Han TH, Lamph WW, Prywes R. Mapping of epidermal growth factor-, serum-, and phorbol ester-responsive sequence elements in the c-jun promoter. Mol Cell Biol 1992;12:4472-7.
27. Johansen FE, Prywes R. Two pathways for serum regulation of the c-fos serum response element require specific sequence elements and a minimal domain of serum response factor. Mol Cell Biol 1994;14:5920-8.
28. Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci U S A 1986;83:2496-500.
29. Ghayur T, Hugunin M, Talanian RV, et al. Proteolytic activation of protein kinase C δ by an ICE/CED 3-like protease induces characteristics of apoptosis. J Exp Med 1996;184:2399-404.
30. Messina JL, Standaert ML, Ishizuka T, Weinstock RS, Farese RV. Role of protein kinase C in insulin's regulation of c-fos transcription. J Biol Chem 1992;267:9223-8.
31. Zhang J, Wang L, Petrin J, Bishop WR, Bond RW. Characterization of site-specific mutants altered at protein kinase C β1 isozyme autophosphorylation sites. Proc Natl Acad Sci U S A 1993;90:6130-4.
32. Soh JW, Lee EH, Prywes R, Weinstein IB. Novel roles of specific isoforms of protein kinase C in activation of the c-fos serum response element. Mol Cell Biol 1999;19:1313-24.
33. Choi PM, Tchou-Wong KM, Weinstein IB. Overexpression of protein kinase C in HT29 colon cancer cells causes growth inhibition and tumor suppression. Mol Cell Biol 1990;10:4650-7.
34. Goldstein DR, Cacace AM, Weinstein IB. Overexpression of protein kinase C β1 in the SW480 colon cancer cell line causes growth suppression. Carcinogenesis 1995;16:1121-6.
35. Svensson K, Zeidman R, Troller U, Schultz A, Larsson C. Protein kinase C β1 is implicated in the regulation of neuroblastoma cell growth and proliferation. Cell Growth Differ 2000;11:641-8.
36. Zhang J, Anastasiadis PZ, Liu Y, Thompson EA, Fields AP. Protein kinase C (PKC) βII induces cell invasion through a Ras/Mek-, PKCι/Rac1- dependent signaling pathway. J Biol Chem 2004;279:22118-23.
37. Sherr CJ. D-type cyclins. Trends Biochem Sci 1995;20:187-90.
38. Cai H, Smola U, Wixler V, et al. Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase. Mol Cell Biol 1997;17:732-41.
39. Marais R, Light Y, Mason C, Paterson H, Olson MF, Marshall CJ. Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C. Science 1998;280:109-12.
40. Ono Y, Kikkawa U, Ogita K, et al. Expression and properties of two types of protein kinase C: alternative splicing from a single gene. Science 1987;236:1116-20.
41. Deacon EM, Pongracz J, Griffiths G, Lord JM. Isoenzymes of protein kinase C: differential involvement in apoptosis and pathogenesis. Mol Pathol 1997;50:124-31.
42. Jiang XH, Tu SP, Cui JT, et al. Antisense targeting protein kinase C α and β1 inhibits gastric carcinogenesis. Cancer Res 2004;64:5787-94.
43. Zhu GH, Wong BC, Slosberg ED, et al. Overexpression of protein kinase C-β1 isoenzyme suppresses indomethacin-induced apoptosis in gastric epithelial cells. Gastroenterology 2000;118:507-14.
44. Jiang XH, Lam SK, Lin MC, et al. Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-β(1)-dependent pathway. Oncogene 2002;21:6113-22.
45. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Barrette TR, Ghosh D, Chinnaiyan AM. Mining for regulatory programs in the cancer transcriptome. Nat Genet 2005;37:579-83.
46. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001;98:10869-74.
47. Perou CM, Jeffrey SS, van de Rijn M, et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci U S A 1999;96:9212-7.
48. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-6.